Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China
Vikalp Kumar Maheshwari, Cassandra Slader, Nidhi Dani, Christina Gkitzia, Quan Yuan, Tengbin Xiong, Yu Liu, Ricardo Viana
Published in PloS one (25.10.2021)
Published in PloS one (25.10.2021)
Get full text
Journal Article
Jugaad CoLab: Decolonial Poetics, Minimal Computing, and South Asian Digital Humanities
Chauhan, Rohan, Ghosh, Agniv, Rizvi, Zahra, Irfan, Saniya, George, Steven S, Rehman, Abdul, Kumar, Vikalp, Pue, A. Sean
Published in Digital studies (19.12.2023)
Published in Digital studies (19.12.2023)
Get full text
Journal Article
Machine learning method using position-specific mutation based classification outperforms one hot coding for disease severity prediction in haemophilia ‘A’
Singh, Vikalp Kumar, Maurya, Neha Shree, Mani, Ashutosh, Yadav, Rama Shankar
Published in Genomics (San Diego, Calif.) (01.11.2020)
Published in Genomics (San Diego, Calif.) (01.11.2020)
Get full text
Journal Article
Decreased pyruvate dehydrogenase activity in Tafazzin-deficient cells is caused by dysregulation of pyruvate dehydrogenase phosphatase 1 (PDP1)
Liang, Zhuqing, Ralph-Epps, Tyler, Schmidtke, Michael W., Kumar, Vikalp, Greenberg, Miriam L.
Published in The Journal of biological chemistry (01.03.2024)
Published in The Journal of biological chemistry (01.03.2024)
Get full text
Journal Article
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors
Atallah, Ehab, Mauro, Michael J., Hochhaus, Andreas, Boquimpani, Carla, Minami, Yosuke, Maheshwari, Vikalp Kumar, Saini, Lovneet, Corbin, Regina, Réa, Delphine
Published in Journal of cancer research and clinical oncology (01.08.2023)
Published in Journal of cancer research and clinical oncology (01.08.2023)
Get full text
Journal Article
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial
Réa, Delphine, Boquimpani, Carla, Mauro, Michael J., Minami, Yosuke, Allepuz, Alex, Maheshwari, Vikalp Kumar, D’Alessio, Denise, Wu, Ying, Lawrance, Rachael, Narbutas, Sarunas, Sharf, Giora, Hochhaus, Andreas
Published in Leukemia (01.05.2023)
Published in Leukemia (01.05.2023)
Get full text
Journal Article
Quality of life (QOL) with ribociclib (RIB) plus aromatase inhibitor (AI) versus abemaciclib (ABE) plus AI as first-line (1L) treatment (tx) of hormone receptor-positive/human epidermal growth factor receptor–negative (HR+/HER2−) advanced breast cancer (ABC), assessed via matching-adjusted indirect comparison (MAIC)
Rugo, Hope S., O'Shaughnessy, Joyce, Jhaveri, Komal L., Tolaney, Sara M., Cardoso, Fatima, Bardia, Aditya, Maheshwari, Vikalp Kumar, Tripathi, Sandeep, Pathak, Purnima, Haftchenary, Sina, Fasching, Peter A.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI)
Mauro, Michael J., Boquimpani, Carla, Réa, Delphine, Hochhaus, Andreas, Maheshwari, Vikalp Kumar, Allepuz, Alex, Patwardhan, Pallavi, Wu, Ying, DeRosa, Michael, Minami, Yosuke
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Poster: CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI)
Mauro, Michael J., Boquimpani, Carla, Réa, Delphine, Hochhaus, Andreas, Maheshwari, Vikalp Kumar, Allepuz, Alex, Patwardhan, Pallavi, Wu, Ying, DeRosa, Michael, Minami, Yosuke
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Quality of life with ribociclib abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison
Hope S. Rugo, Victoria Harmer, Joyce O’Shaughnessy, Komal Jhaveri, Sara M. Tolaney, Fatima Cardoso, Aditya Bardia, Vikalp Kumar Maheshwari, Sandeep Tripathi, Sina Haftchenary, Purnima Pathak, Peter A. Fasching
Published in Therapeutic advances in medical oncology (01.02.2023)
Published in Therapeutic advances in medical oncology (01.02.2023)
Get full text
Journal Article
Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison
Rugo, Hope S., Harmer, Victoria, O’Shaughnessy, Joyce, Jhaveri, Komal, Tolaney, Sara M., Cardoso, Fatima, Bardia, Aditya, Maheshwari, Vikalp Kumar, Tripathi, Sandeep, Haftchenary, Sina, Pathak, Purnima, Fasching, Peter A.
Published in Therapeutic advances in medical oncology (01.01.2023)
Published in Therapeutic advances in medical oncology (01.01.2023)
Get full text
Journal Article
Missing Data: Its Emergence in the Real-world-A Practical Review on Google Play Apps dataset using Python
Tripathi, Vikalp Kumar, Parashar, Pratyush, Rao K, Mallikharjuna
Published in 2022 IEEE IAS Global Conference on Emerging Technologies (GlobConET) (20.05.2022)
Published in 2022 IEEE IAS Global Conference on Emerging Technologies (GlobConET) (20.05.2022)
Get full text
Conference Proceeding